Cline Christopher R.

CIK 1943192
Transactions on file
25

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-09-182026-09-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale400$26.1K-23.3%open →
2026-09-182026-09-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale1,900$121.0K-21.4%open →
2026-09-182026-09-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale20,735$1.30M-20.0%open →
2026-09-182026-09-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale27,473$1.70M-19.2%open →
2026-09-182026-09-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Exer.20,000$348.8K+187.2%open →
2026-09-032026-09-02TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale642$42.6K-24.5%open →
2026-04-152026-04-15TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale1,014$43.2K+17.5%open →
2026-04-152026-04-14TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale7,239$303.5K+19.4%open →
2026-04-152026-04-14TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale9$369.63+21.9%open →
2026-04-152026-04-13TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale65$1.9K+73.6%open →
2026-04-152026-04-13TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Grant14,000$0.00—open →
2025-01-232025-01-22TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale865$16.4K+164.4%open →
2025-02-042025-01-31TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Grant21,500$0.00—open →
2025-02-042025-02-03TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale5,192$104.5K+148.9%open →
2025-04-142025-04-11TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale48$630.72+281.1%open →
2025-05-052025-05-05TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale1,784$37.6K+137.9%open →
2025-05-052025-05-02TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Exer.4,920——open →
2026-05-072026-05-06TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale310$13.6K+13.9%open →
2026-05-072026-05-05TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale2,181$101.7K+7.4%open →
2026-05-072026-05-04TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Exer.4,250$0.00—open →
2025-12-032025-12-01TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Sale20,000$700.2K+43.0%open →
2025-12-032025-12-01TVTX
Travere Therapeutics, Inc.
CHIEF FINANCIAL OFFICER
Exer.20,000$324.6K+208.6%open →
2025-08-282025-08-27TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale470$8.1K+189.3%open →
2025-09-052025-09-04TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale119$2.3K+154.1%open →
2025-09-052025-09-03TVTX
Travere Therapeutics, Inc.
Officer
CHIEF FINANCIAL OFFICER
Sale454$8.3K+175.2%open →